• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较犬和猫血管肉瘤的致癌基因组图谱显示出与人类血管肉瘤的新相似之处。

Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.

机构信息

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Department of Pathobiology, University of Guelph, 50 Stone Road E., Guelph, ON N1G 2W1, Canada.

出版信息

Dis Model Mech. 2021 Jul 1;14(7). doi: 10.1242/dmm.049044. Epub 2021 Jul 23.

DOI:10.1242/dmm.049044
PMID:34296746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8319545/
Abstract

Angiosarcoma (AS) is a highly aggressive tumor of blood and lymphatic vessels in humans that shares many similarities with spontaneously occurring hemangiosarcoma (HSA) in dogs and cats. To investigate the genetic suitability of HSA as a model for AS, we sequenced ∼1000 cancer genes in 41 cases of HSA and matched germline tissue: 15 canine visceral HSAs, 13 canine skin HSAs and 13 feline skin HSAs. Analysis of visceral HSAs from dogs presenting with concurrent splenic and cardiac neoplasms showed that the tumors were not independent primaries, consistent with the highly metastatic nature of HSA. Comparison of HSA to AS revealed that several driver genes were recurrently mutated in both species, such as TP53, PIK3CA, ATRX, GRIN2A and LRP1B. Similar to AS, a UV mutational signature was found in a subset of canine cutaneous HSAs and both species show differing mutational profiles between tissue sites. Our characterization of canine and feline HSA demonstrates many important parallels to AS and provides hope that future studies on these cancers will benefit of all three species.

摘要

血管肉瘤(AS)是一种人类血液和淋巴管的高度侵袭性肿瘤,与犬猫自发性发生的血管肉瘤(HSA)有许多相似之处。为了研究 HSA 是否适合作为 AS 的模型,我们对 41 例 HSA 及其相应的种系组织进行了约 1000 个癌症基因的测序:15 例犬内脏 HSA、13 例犬皮肤 HSA 和 13 例猫皮肤 HSA。对同时存在脾脏和心脏肿瘤的犬内脏 HSA 的分析表明,这些肿瘤不是独立的原发性肿瘤,这与 HSA 的高度转移性一致。HSA 与 AS 的比较表明,两种物种中都有几个驱动基因经常发生突变,如 TP53、PIK3CA、ATRX、GRIN2A 和 LRP1B。与 AS 相似,在一组犬皮肤 HSA 中发现了紫外线突变特征,两种物种在组织部位之间显示出不同的突变特征。我们对犬和猫 HSA 的描述表明,与 AS 有许多重要的相似之处,并希望未来对这些癌症的研究将受益于这三个物种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/562c47ee21b4/dmm-14-049044-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/5d9c7369d08e/dmm-14-049044-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/b7db29fe029e/dmm-14-049044-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/4d426a0d6e62/dmm-14-049044-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/562c47ee21b4/dmm-14-049044-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/5d9c7369d08e/dmm-14-049044-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/b7db29fe029e/dmm-14-049044-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/4d426a0d6e62/dmm-14-049044-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eee/8319545/562c47ee21b4/dmm-14-049044-g4.jpg

相似文献

1
Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.比较犬和猫血管肉瘤的致癌基因组图谱显示出与人类血管肉瘤的新相似之处。
Dis Model Mech. 2021 Jul 1;14(7). doi: 10.1242/dmm.049044. Epub 2021 Jul 23.
2
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.犬脾脏血管肉瘤(血管肉瘤)的基因组景观在患者内部和之间存在广泛的异质性。
PLoS One. 2022 Jul 22;17(7):e0264986. doi: 10.1371/journal.pone.0264986. eCollection 2022.
3
Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.比较基因组学揭示了犬血管肉瘤和人类血管肉瘤的共同突变特征。
Mol Cancer Res. 2019 Dec;17(12):2410-2421. doi: 10.1158/1541-7786.MCR-19-0221. Epub 2019 Sep 30.
4
Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.犬血管肉瘤的分子亚型与人类血管肉瘤具有相似性。
PLoS One. 2020 Mar 25;15(3):e0229728. doi: 10.1371/journal.pone.0229728. eCollection 2020.
5
Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma.真实世界证据将基因组生物标志物与犬血管肉瘤的治疗结果相关联。
Sci Rep. 2025 May 14;15(1):16442. doi: 10.1038/s41598-025-89862-9.
6
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.犬脾脏血管肉瘤中具有临床意义的基因组改变的鉴定
Vet Comp Oncol. 2023 Dec;21(4):623-633. doi: 10.1111/vco.12925. Epub 2023 Sep 21.
7
Hemangiosarcoma in dogs and cats.犬猫血管肉瘤
Vet Clin North Am Small Anim Pract. 2003 May;33(3):533-52, vi. doi: 10.1016/s0195-5616(03)00002-0.
8
Actionable mutations in canine hemangiosarcoma.犬血管肉瘤中的可操作突变。
PLoS One. 2017 Nov 30;12(11):e0188667. doi: 10.1371/journal.pone.0188667. eCollection 2017.
9
Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.染色质转录延伸测序分析发现,细胞外基质重塑在犬血管肉瘤发病机制中发挥重要作用。
BMC Vet Res. 2020 Jun 22;16(1):206. doi: 10.1186/s12917-020-02395-3.
10
Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.血小板衍生生长因子及其受体在自发性犬血管肉瘤和皮肤血管瘤中的表达。
Histol Histopathol. 2012 May;27(5):601-7. doi: 10.14670/HH-27.601.

引用本文的文献

1
The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification.K9 淋巴瘤检测法可以对犬类淋巴瘤进行遗传亚群分类,从而改善风险分类。
Sci Rep. 2024 Aug 12;14(1):18687. doi: 10.1038/s41598-024-69716-6.
2
Application value of F-FDG PET/CT in primary spleen angiosarcoma with liver metastasis: a case report and literature review.F-FDG PET/CT在原发性脾血管肉瘤伴肝转移中的应用价值:1例病例报告并文献复习
Front Oncol. 2024 May 24;14:1366560. doi: 10.3389/fonc.2024.1366560. eCollection 2024.
3
Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future.

本文引用的文献

1
A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs.一项针对犬 PD-1 治疗性抗体治疗犬晚期自发性癌症的临床前研究。
Sci Rep. 2020 Oct 27;10(1):18311. doi: 10.1038/s41598-020-75533-4.
2
A new domestic cat genome assembly based on long sequence reads empowers feline genomic medicine and identifies a novel gene for dwarfism.基于长序列读段的新型家猫基因组组装为猫科基因组医学提供助力,并鉴定出一个新的 dwarfism 相关基因。
PLoS Genet. 2020 Oct 22;16(10):e1008926. doi: 10.1371/journal.pgen.1008926. eCollection 2020 Oct.
3
Improving human cancer therapy through the evaluation of pet dogs.
分子生物标志物在犬猫肿瘤学中的临床应用:现状与未来
Vet Sci. 2024 May 2;11(5):199. doi: 10.3390/vetsci11050199.
4
Tumor Immune Microenvironment and Its Clinicopathological and Prognostic Associations in Canine Splenic Hemangiosarcoma.犬脾脏血管肉瘤的肿瘤免疫微环境及其临床病理和预后相关性
Animals (Basel). 2024 Apr 18;14(8):1224. doi: 10.3390/ani14081224.
5
Bringing the Genomic Revolution to Comparative Oncology: Human and Dog Cancers.将基因组革命引入比较肿瘤学:人类癌症和犬类癌症。
Annu Rev Biomed Data Sci. 2024 Aug;7(1):107-129. doi: 10.1146/annurev-biodatasci-102423-111936. Epub 2024 Jul 24.
6
[Comparative pathology in oncology-Best practice].[肿瘤学中的比较病理学——最佳实践]
Pathologie (Heidelb). 2024 May;45(3):190-197. doi: 10.1007/s00292-024-01327-4. Epub 2024 Apr 11.
7
Review of Molecular Technologies for Investigating Canine Cancer.用于研究犬类癌症的分子技术综述
Animals (Basel). 2024 Feb 29;14(5):769. doi: 10.3390/ani14050769.
8
Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.犬血管肉瘤作为人类血管肉瘤药物发现研究的潜在非啮齿类动物模型。
Front Oncol. 2023 Dec 7;13:1250766. doi: 10.3389/fonc.2023.1250766. eCollection 2023.
9
Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA.犬脾脏血管肉瘤组织及游离DNA中的甲基化状态
Animals (Basel). 2023 Sep 21;13(18):2987. doi: 10.3390/ani13182987.
10
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer.种间致癌基因组学为研究人类肌肉浸润性膀胱癌提供了新视角。
Genome Biol. 2023 Aug 28;24(1):191. doi: 10.1186/s13059-023-03026-4.
通过评估宠物狗来提高人类癌症疗法。
Nat Rev Cancer. 2020 Dec;20(12):727-742. doi: 10.1038/s41568-020-0297-3. Epub 2020 Sep 15.
4
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.血管肉瘤异质性和免疫检查点阻断治疗的潜在脆弱性:来自基因组测序的见解。
Genome Med. 2020 Jul 9;12(1):61. doi: 10.1186/s13073-020-00753-2.
5
Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives.癌症的顶尖靶向策略:近期见解和当前观点的详细概述。
Cells. 2020 Jun 20;9(6):1503. doi: 10.3390/cells9061503.
6
Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.犬血管肉瘤的分子亚型与人类血管肉瘤具有相似性。
PLoS One. 2020 Mar 25;15(3):e0229728. doi: 10.1371/journal.pone.0229728. eCollection 2020.
7
The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.血管肉瘤计划:通过患者合作研究,在罕见癌症中实现基因组和临床发现。
Nat Med. 2020 Feb;26(2):181-187. doi: 10.1038/s41591-019-0749-z. Epub 2020 Feb 10.
8
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
9
Angiosarcoma: a review of diagnosis and current treatment.血管肉瘤:诊断与当前治疗综述
Am J Cancer Res. 2019 Nov 1;9(11):2303-2313. eCollection 2019.
10
Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.比较基因组学揭示了犬血管肉瘤和人类血管肉瘤的共同突变特征。
Mol Cancer Res. 2019 Dec;17(12):2410-2421. doi: 10.1158/1541-7786.MCR-19-0221. Epub 2019 Sep 30.